Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-023111
Filing Date
2019-11-18
Accepted
2019-11-18 15:04:26
Documents
57
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc20190930_10q.htm 10-Q 742467
2 EXHIBIT 31.1 ex_165090.htm EX-31.1 15076
3 EXHIBIT 32.1 ex_165092.htm EX-32.1 7791
10 tlcc20190930_10qimg001.jpg GRAPHIC 5269
  Complete submission text file 0001437749-19-023111.txt   5096681

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tlcc-20190930.xml EX-101.INS 1087893
5 XBRL TAXONOMY EXTENSION SCHEMA tlcc-20190930.xsd EX-101.SCH 58333
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlcc-20190930_cal.xml EX-101.CAL 37886
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlcc-20190930_def.xml EX-101.DEF 366259
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlcc-20190930_lab.xml EX-101.LAB 322472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlcc-20190930_pre.xml EX-101.PRE 390401
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 191227325
SIC: 2833 Medicinal Chemicals & Botanical Products